Related Experiment Video
Updated: May 8, 2026

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
Epigenetics of hepatocellular carcinoma: role of microRNA
Sharad Khare1, Qiong Zhang, Jamal A Ibdah
1Sharad Khare, Qiong Zhang, Jamal A Ibdah, Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Missouri, Columbia, MO 65212, United States.
Abstract:
Hepatocellular carcinoma (HCC) represents a major form of primary liver cancer in adults. MicroRNAs (miRs), small non-coding single-stranded RNAs of 19-24 nucleotides in length, negatively regulate the expression of many target genes at the post-transcriptional and/or translational levels and play a critical role in the initiation and progression of HCC. In this review we have summarized the information of aberrantly expressed miRs in HCC, their mechanism of action and relationship to cancer. The recent advances in HCC research reveal that miRs regulate expression of various oncogenes and tumor suppressor genes, thereby contributing to the modulation of diverse biological processes including proliferation, apoptosis, epithelial to mesenchymal transition and metastasis. From a clinical viewpoint, polymorphisms within miR-binding sites are associated with the risk of HCC. Polymorphisms in miR related genes have been shown to correlate with survival or treatment outcome in patients. Furthermore, the review focuses on the potential role of miRs as novel biomarkers and their translational applications for diagnosis and therapy in HCC. With further insights into miR deregulation in HCC, it is expected that novel miR-based therapeutics will arise. Also, we orient the readers to other reviews that may provide better understanding of miR research in HCC.
Insights
MicroRNAs (miRs) are crucial in hepatocellular carcinoma (HCC) development, regulating genes involved in cancer progression. Aberrantly expressed miRs offer potential as biomarkers and therapeutic targets for liver cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Hepatocellular carcinoma (HCC) is a primary liver cancer with significant mortality.
- MicroRNAs (miRs) are small non-coding RNAs regulating gene expression post-transcriptionally.
- miRs play a critical role in the initiation and progression of HCC.
Purpose of the Study:
- To review aberrantly expressed miRs in HCC, their mechanisms, and cancer relevance.
- To highlight the role of miRs in regulating oncogenes and tumor suppressor genes.
- To discuss the clinical implications of miR polymorphisms and the potential of miRs in HCC diagnosis and therapy.
Main Methods:
- Literature review of studies on microRNAs in hepatocellular carcinoma.
- Analysis of miR expression patterns, mechanisms of action, and clinical associations.
- Synthesis of current research on miR biomarkers and therapeutic applications.
Main Results:
- miRs are deregulated in HCC, influencing proliferation, apoptosis, EMT, and metastasis.
- miR-binding site polymorphisms are linked to HCC risk.
- Polymorphisms in miR-related genes correlate with patient survival and treatment outcomes.
- miRs show promise as diagnostic biomarkers and therapeutic targets for HCC.
Conclusions:
- Aberrantly expressed miRs are key players in HCC pathogenesis.
- miRs and their genetic variations have significant clinical implications for HCC.
- miRs represent a promising avenue for novel diagnostic and therapeutic strategies in HCC management.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Cell Specific Gene Expression
Epigenetic Regulation
lncRNA - Long Non-coding RNAs

